Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India.
Patel A, Bhatt N, Prakash SS, Biswas G, Nagarkar R, Roy B, Samal P, Agrawal N, Meshram S, Kaushal A, Satheesh CT, Wategaonkar R, Thiagarajan KV, Jain K, Vijayaveeran P, Mukherjee K, Singh K, Patil T, Jain A, Dolai TK, Jain M, Hingmire S, Gupta TC, Lakshmaiah KC, Rajamanickam D, Nemade B, Goyal V, Mahato P, Mendiratta SK, Doshi M. Patel A, et al. Among authors: biswas g. Cancer Chemother Pharmacol. 2023 Jun;91(6):457-468. doi: 10.1007/s00280-023-04530-x. Epub 2023 Apr 24. Cancer Chemother Pharmacol. 2023. PMID: 37093266 Free PMC article. Clinical Trial.
A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.
Sinha SD, Biswas G, Bheemareddy BR, Chary S, Thakur P, Jain M, Maksud T, Pawar S, Chatterjee K, Voonna MK, Goel A, Puligundla KC, Lakshmaiah KC, Talluri L, Vattipalli R, Kakkunnath S. Sinha SD, et al. Among authors: biswas g. Cancer Inform. 2023 Jun 1;22:11769351231177277. doi: 10.1177/11769351231177277. eCollection 2023. Cancer Inform. 2023. PMID: 37313371 Free PMC article.
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study.
Kumar L, Melinkeri S, Ganesan P, Kumar J, Biswas G, Kilara N, Pathalingappa H, Prasad S, Jain M, Mishra SK, Prasad S, Boyella PK, Sahoo RK, Bondarde S, Shah S, Rege M, Deb U, Korde T, Dixit J. Kumar L, et al. Among authors: biswas g. Future Oncol. 2024 Feb;20(4):191-205. doi: 10.2217/fon-2023-0842. Epub 2023 Dec 20. Future Oncol. 2024. PMID: 38116642 Clinical Trial.
Practical Consensus Guidelines for the Use of S-1 in GI Malignancies.
Parikh PM, Sahoo TP, Biswas G, Talwar V, Sp S, Panda SS, Cb A, Shetty N, Ramesh A, Ghosh J, Shetty VV, Naik R, Singh A, Gupta G, Parekh B. Parikh PM, et al. Among authors: biswas g. South Asian J Cancer. 2024 Feb 5;13(1):77-82. doi: 10.1055/s-0043-1778685. eCollection 2024 Jan. South Asian J Cancer. 2024. PMID: 38721104 Free PMC article.
338 results